Sex Differences in the Safety and Subjective Effects of Two Oral Δ9-Tetrahydrocannabinol-Containing Cannabis Products over Multiple Doses Among Healthy Adults
Cannabis and Cannabinoid Research · 01.08.2024 · 9 (4) · 967-978
DOI: 10.1089/can.2022.0340 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Cannabis and Cannabinoid Research, erschienen am 01.08.2024. Verfasst von Laura MacNair und 4 weiteren Autor:innen. Beteiligte Einrichtung: Canopy Growth Corporation, Smiths Falls, Ontario, Canada. Hauptthemen laut MEDLINE: Cannabis, Dronabinol, Sex Characteristics. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Canopy Growth Corporation, Smiths Falls, Ontario, Canada.
ORCID-Profile: Marcel O Bonn-Miller, Erica N Peters
Zitieren
APA
MacNair, L., Eglit, G. M. L., Mosesova, I., Bonn-Miller, M. O., & Peters, E. N. (2024). Sex Differences in the Safety and Subjective Effects of Two Oral Δ9-Tetrahydrocannabinol-Containing Cannabis Products over Multiple Doses Among Healthy Adults. Cannabis and Cannabinoid Research, 9(4), 967-978. https://doi.org/10.1089/can.2022.0340
Vancouver
MacNair L, Eglit GML, Mosesova I, Bonn-Miller MO, Peters EN. Sex Differences in the Safety and Subjective Effects of Two Oral Δ9-Tetrahydrocannabinol-Containing Cannabis Products over Multiple Doses Among Healthy Adults. Cannabis and Cannabinoid Research. 2024;9(4):967-978. doi:10.1089/can.2022.0340
BibTeX
@article{MacNair2024,
author = {MacNair, Laura and Eglit, Graham M L and Mosesova, Irina and Bonn-Miller, Marcel O and Peters, Erica N},
title = {Sex Differences in the Safety and Subjective Effects of Two Oral Δ9-Tetrahydrocannabinol-Containing Cannabis Products over Multiple Doses Among Healthy Adults},
journal = {Cannabis and Cannabinoid Research},
year = {2024},
volume = {9},
number = {4},
pages = {967--978},
doi = {10.1089/can.2022.0340}
}
EUVIMED